Skip to main content
Caplight Logo









AmpliGene India Biotech

AmpliGene India Biotech

Private
AhmedabadHealthcare & Life Scienceshttps://ampligeneindia.com/

Last Round

Accelerator

Jul 1, 2026

Total Funding Raised

$230,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

AmpliGene India Biotech is a biotechnology company that develops molecular diagnostic solutions, including isothermal amplification technology and point-of-care testing systems for clinical, veterinary, and agricultural applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Usage-Based SaaS

AI Layer

Non-AI

Keywords

point-of-care testingPOCTisothermal amplificationmolecular diagnosticsLAMPportable diagnosticpathogen detectiondiagnostic kitsrapid testingfield diagnosticsnucleic acid amplificationfood safety testingveterinary diagnosticsassay developmentcontract manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AmpliGene India Biotech Comparables

Compare AmpliGene India Biotech with similar companies based on industry and business-model similarity.

AmpliGene India Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
OptiGene Limited
85%
Achira Labs Private Limited
80%
Huwel Lifesciences
80%

AmpliGene India Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJul 1, 2026

AmpliGene India Biotech Investors

Notable investors and investment history

AmpliGene India Biotech investors
InvestorRounds
Centre for Cellular and Molecular PlatformsAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2026

    $230K raised from Centre for Cellular and Molecular Platforms and global-amr-innovation-fund.

AmpliGene India Biotech Filings

Explore SEC and related filing metadata, where available.

AmpliGene India Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AmpliGene India Biotech's valuation, stock price, and market status.

Is AmpliGene India Biotech a public or private company?

AmpliGene India Biotech is a private company.

What is the current stock price of AmpliGene India Biotech?

AmpliGene India Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is AmpliGene India Biotech worth (valuation)?

Valuation information for AmpliGene India Biotech is not publicly available.

Can I buy AmpliGene India Biotech stock?

AmpliGene India Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AmpliGene India Biotech's last funding round?

AmpliGene India Biotech's most recent funding round was Accelerator on July 1, 2026.

Who are the main investors in AmpliGene India Biotech?

Key investors in AmpliGene India Biotech include Centre for Cellular and Molecular Platforms.

Will AmpliGene India Biotech IPO soon?

No public IPO plans have been announced for AmpliGene India Biotech.

How can I track AmpliGene India Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AmpliGene India Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAhmedabad
Year Founded2012
Last FundingJul 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?